AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 136 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $30,000 | -99.2% | 10,124 | -94.7% | 0.00% | -100.0% |
| Q2 2015 | $3,599,000 | -60.1% | 189,734 | -45.0% | 0.01% | -57.1% |
| Q1 2015 | $9,021,000 | +252.9% | 344,711 | +182.4% | 0.02% | +250.0% |
| Q4 2014 | $2,556,000 | -16.1% | 122,078 | +33.7% | 0.01% | -14.3% |
| Q3 2014 | $3,047,000 | +6.5% | 91,281 | +2.4% | 0.01% | 0.0% |
| Q2 2014 | $2,861,000 | -33.3% | 89,137 | -4.1% | 0.01% | -41.7% |
| Q1 2014 | $4,291,000 | -13.7% | 92,913 | +32.6% | 0.01% | -20.0% |
| Q4 2013 | $4,974,000 | -4.8% | 70,087 | +15.0% | 0.02% | -21.1% |
| Q3 2013 | $5,225,000 | +53.7% | 60,960 | +13.6% | 0.02% | +35.7% |
| Q2 2013 | $3,399,000 | – | 53,662 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 447,001 | $14,344,000 | 100.00% |
| Broadfin Capital, LLC | 1,620,088 | $51,988,000 | 2.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,899,585 | $93,048,000 | 2.40% |
| Tamarack Capital Management, LLC | 400,000 | $11,656,000 | 2.38% |
| March Altus Capital Management LP | 199,037 | $6,387,000 | 2.34% |
| PRICE MICHAEL F | 240,000 | $7,702,000 | 0.94% |
| DELTEC ASSET MANAGEMENT LLC | 106,151 | $3,406,000 | 0.72% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,207,598 | $102,932,000 | 0.61% |
| CLOUGH CAPITAL PARTNERS L P | 508,800 | $16,327,000 | 0.52% |
| Catalyst Capital Advisors LLC | 86,500 | $2,776,000 | 0.45% |